TearClear is an emerging ophthalmic pharmaceutical company with the goal of disrupting the way current topical medications are delivered to the ocular surface. Our lead product candidates in glaucoma will pave the way for future indications across multiple programs in development. This first in class platform of drugs enables medication delivery to ultimately enhance patient safety and compliance by capturing preservatives before they reach the ocular surface.
| Website | http://www.tearclear.com |
| Employees | 6 (3 on RocketReach) |
| Founded | 2015 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Chemical Engineering, Science and Engineering, Medical Device, Health Care, Pharmaceutical |
| Keywords | Glaucoma Treatment, Ophthalmic Pharmaceuticals, Ophthalmology, Ocular Therapeutics, Drug Delivery Technology, Eye Disease Treatment, Eye Care Products, Innovative Eye Care, Vision Care, Pharmaceutical Innovation, New Drug Development |
| Competitors | Johnson & Johnson, Xerox, Alcon, Bausch + Lomb, Shire, Valeant Pharmaceuticals, Santen, Actavis plc (now Allergan), LIPIFLOW, Advanced Vision Research , Inc. +36 more (view full list) |
Looking for a particular TearClear employee's phone or email?
TearClear Questions
Srini Venkatesh is the CEO of TearClear.
3 people are employed at TearClear.
TearClear is based in Boston, Massachusetts.
Top TearClear Employees
-
Srini Venkatesh
Chief Executive Officer at TearClear
United States15+ -
Mike Williams
Senior Chemist at TearClear
Gainesville, FL, US14
